RxSight (RXST) Profit After Tax (QoQ) (2020 - 2026)
RxSight (RXST) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | RxSight | 230.69 Mn | -187.51 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.79% |
| Dec 31, 2025 | -295.67% |
| Sep 30, 2025 | 16.71% |
| Jun 30, 2025 | -41.30% |
| Mar 31, 2025 | -40.47% |
| Dec 31, 2024 | 6.31% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | 33.20% |
| Mar 31, 2024 | -0.14% |
| Dec 31, 2023 | 26.73% |
| Sep 30, 2023 | 10.16% |
| Jun 30, 2023 | -4.48% |
| Mar 31, 2023 | 15.36% |
| Dec 31, 2022 | 6.93% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | 4.91% |
| Mar 31, 2022 | 63.85% |
| Dec 31, 2021 | -284.12% |
| Sep 30, 2021 | 5.97% |
| Jun 30, 2021 | -98.05% |